StandardAero (NYSE: SARO) announced results today for the three months ended September 30, 2025 ("Third Quarter 2025").

With new draft guidance, FDA continues prior efforts to reduce the need for comparative clinical studies in biosimilar development and speed ...

Q3 2025 Earnings Call November 7, 2025 8:30 AM ESTCompany ParticipantsBob BelknappKenneth Tuchman - Founder, Chairman ...

Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion ...

Background Although voting is recognised as a social determinant of health, the association between electoral participation ...

Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsGiovanni PacelliRobert Johnson - CEO, President ...

Artificial intelligence is transforming how employers recruit and evaluate talent. According to industry research, the ...